Zimmer Biomet (ZBH.SW) started trading on February 27, 2026, as the top pre-market loser on the SIX Swiss Exchange, declining -4.26% to CHF67.50. This drop is attributed to weak near-term momentum and a significant gap from its 50- and 200-day averages, alongside low liquidity amplifying the price movement. While Meyka AI gives ZBH.SW a B+ grade with a “BUY” suggestion, forecasts indicate potential further downside for the stock, urging traders to watch for the May 2026 earnings report and the CHF67.50 support level.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Pre-market top loser ZBH.SW Zimmer Biomet -4.26% on 27 Feb 2026: support CHF67.50
Zimmer Biomet (ZBH.SW) started trading on February 27, 2026, as the top pre-market loser on the SIX Swiss Exchange, declining -4.26% to CHF67.50. This drop is attributed to weak near-term momentum and a significant gap from its 50- and 200-day averages, alongside low liquidity amplifying the price movement. While Meyka AI gives ZBH.SW a B+ grade with a “BUY” suggestion, forecasts indicate potential further downside for the stock, urging traders to watch for the May 2026 earnings report and the CHF67.50 support level.